NOVARTIS N - Dusseldorf Stock Exchang
NOVARTIS N - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
NOVARTIS N - Dusseldorf Stock Exchang (NOT) - Total Liabilities
Latest total liabilities as of September 2024: €60.08 Billion EUR
Based on the latest financial reports, NOVARTIS N - Dusseldorf Stock Exchang (NOT) has total liabilities worth €60.08 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NOVARTIS N - Dusseldorf Stock Exchang - Total Liabilities Trend (2016–2023)
This chart illustrates how NOVARTIS N - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NOVARTIS N - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of NOVARTIS N - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Odyssey Resources Limited
V:ODX-H
|
Canada | CA$1.80K |
|
OPS Retail S.p.A.
F:DMM
|
Germany | €61.42 Million |
|
BioSenic S.A.
BR:BIOS
|
Belgium | €28.10 Million |
|
Orian Sh.M. Ltd
TA:ORIN
|
Israel | ILA1.30 Billion |
|
MeaTech 3D Ltd
PINK:MTTCF
|
USA | $1.75 Million |
|
Blende Silver Corp.
OTCQB:BAGGF
|
USA | $762.79K |
|
Evolution Metals & Technologies Corp. Common Stock
NASDAQ:EMAT
|
USA | $12.63 Million |
|
Simbhaoli Sugars Limited
NSE:SIMBHALS
|
India | ₹17.26 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down NOVARTIS N - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NOVARTIS N - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NOVARTIS N - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual total liabilities of NOVARTIS N - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €53.20 Billion | -8.33% |
| 2022-12-31 | €58.03 Billion | -9.29% |
| 2021-12-31 | €63.97 Billion | -10.04% |
| 2020-12-31 | €71.11 Billion | +13.20% |
| 2019-12-31 | €62.82 Billion | -6.06% |
| 2018-12-31 | €66.87 Billion | +13.63% |
| 2017-12-31 | €58.85 Billion | +6.55% |
| 2016-12-31 | €55.23 Billion | -- |